Literature DB >> 3681586

Neonatal hemochromatosis: failure of deferoxamine therapy.

M M Jonas1, Y A Kaweblum, R Fojaco.   

Abstract

We describe a premature neonate with severe hepatic dysfunction from birth which progressed to fatal hepatic failure at 3 months of age. The diagnosis of a familial disorder, neonatal hemochromatosis, was made, and therapy was attempted with deferoxamine. Features of iron metabolism are presented, and this infant's illness is contrasted with other liver diseases of infancy associated with hepatic iron overload.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3681586

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  3 in total

1.  Neonatal hemochromatosis. The regulation of transferrin-receptor and ferritin synthesis by iron in cultured fibroblastic-line cells.

Authors:  A S Knisely; J B Harford; R D Klausner; S R Taylor
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

2.  Recurrence of neonatal haemochromatosis in half sibs born of unaffected mothers.

Authors:  A Verloes; I K Temple; A F Hubert; P Hope; S Gould; C Debauche; G Verellen; J L Deville; L Koulischer; E M Sokal
Journal:  J Med Genet       Date:  1996-06       Impact factor: 6.318

3.  Hepatic morphology and iron quantitation in perinatal hemochromatosis. Comparison with a large perinatal control population, including cases with chronic liver disease.

Authors:  M M Silver; L S Valberg; E Cutz; L D Lines; M J Phillips
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.